Cargando…
Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa–induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways
Gram-negative pathogen–induced nosocomial infections and resistance are a most serious menace to global public health. Qingfei Xiaoyan Wan (QF), a traditional Chinese medicine (TCM) formula, has been used clinically in China for the treatment of upper respiratory tract infections, acute or chronic b...
Autores principales: | Hou, Yuanyuan, Nie, Yan, Cheng, Binfeng, Tao, Jin, Ma, Xiaoyao, Jiang, Min, Gao, Jie, Bai, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856955/ https://www.ncbi.nlm.nih.gov/pubmed/27175332 http://dx.doi.org/10.1016/j.apsb.2016.03.002 |
Ejemplares similares
-
Qingfei Xiaoyan Wan alleviates asthma through multi-target network regulation
por: Zhao, Zhenying, et al.
Publicado: (2013) -
Searching for Synergistic Bronchodilators and Novel Therapeutic Regimens for Chronic Lung Diseases from a Traditional Chinese Medicine, Qingfei Xiaoyan Wan
por: Hou, Yuanyuan, et al.
Publicado: (2014) -
Systematic identification of the interventional mechanism of Qingfei Xiaoyan Wan (QFXYW) in treatment of the cytokine storm in acute lung injury using transcriptomics-based system pharmacological analyses
por: Hou, Jing-Yi, et al.
Publicado: (2022) -
Qingfei Tongluo Formula Mitigates Mycoplasma pneumoniae Infection via the PERK Signaling Pathway
por: Liu, Xiuxiu, et al.
Publicado: (2022) -
Quality Evaluation of Traditional Chinese Medicine Compounds in Xiaoyan Lidan Tablets: Fingerprint and Quantitative Analysis Using UPLC-MS
por: Yang, Na, et al.
Publicado: (2016)